AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

UPDATE 2-Pfizer ads for Celebrex, Bextra mislead, says FDA.

The America's Intelligence Wire

| January 12, 2005 | COPYRIGHT 2003 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From CBS Marketwatch (Stories))

WASHINGTON (CBS.MW) -- The U.S. Food and Drug Administration has warned Pfizer in a letter that its ads for arthritis drugs Celebrex and Bextra are misleading.

The FDA said in a letter dated Jan. 10 and released on Wednesday that Pfizer failed to disclose information on risks in different advertising campaigns and made "unsubstantiated effectiveness claims" in its ads. The letter alleged Pfizer violated provisions of the U.S. Food, Drug and Cosmetic Act.

Joan Hankin, an FDA consumer promotion analyst, sent a letter to Robert B. Clark, Pfizer's vice president of regulatory affairs. In it, she said the agency focused …

Related articles from newspapers, magazines, journals, and more
Pharmacia/Pfizer: Celebrex Safety Profile is Well-Established.
Press release article from: PR Newswire August 22, 2001 700+ words
...PRNewswire/ -- Pharmacia and Pfizer today strongly reiterated...efficacy and safety of Celebrex (celecoxib capsules...many patients who take Celebrex for symptoms of these diseases. Pharmacia and Pfizer emphasized that their...confident that the extensive Celebrex clinical trials program...
Study raises questions about safety of Pfizer's Celebrex.(Supplier News)
Magazine article from: Chain Drug Review January 3, 2005 700+ words
...the COX-2 class of drugs. Celebrex, Pfizer's Bextra and Vioxx--the...of worldwide development for Pfizer. "Celebrex is an important medicine that...information on heart risks from Celebrex. Pfizer chairman and chief executive...
Pfizer Statement On New Information Regarding Cardiovascular Safety of Celebrex.
Press release article from: PR Newswire December 17, 2004 700+ words
...COX-2 inhibitor Celebrex (celecoxib) based...As reported to Pfizer by the Data Safety...Hank McKinnell, Pfizer chairman and chief executive officer. Celebrex is approved for...development for Pfizer. "Celebrex is an important...
UPDATE 9-Pfizer plunges as cardiac risk found in Celebrex study.
News wire article from: The America's Intelligence Wire December 17, 2004 700+ words
...earnings. He doubted Pfizer would pull Celebrex or its alternative arthritis...is the probability that Pfizer removes Celebrex or Bextra from the market...rheumatoid arthritis. Pfizer's announcement on Celebrex comes three months after...
UPDATE 7-Pfizer plunges as cardiac risk found in Celebrex study.
News wire article from: The America's Intelligence Wire December 17, 2004 700+ words
...earnings. He doubted Pfizer would pull Celebrex or its alternative arthritis...is the probability that Pfizer removes Celebrex or Bextra from the market...market capitalization. Pfizer's announcement on Celebrex comes after rival Merck...
UPDATE 6-Pfizer plunges as cardiac risk found in Celebrex study.
News wire article from: The America's Intelligence Wire December 17, 2004 700+ words
...earnings. He doubted Pfizer would pull Celebrex or its alternative arthritis...is the probability that Pfizer removes Celebrex or Bextra from the market...market capitalization. Pfizer's announcement on Celebrex comes after rival Merck...
UPDATE 8-Pfizer plunges as cardiac risk found in Celebrex study.
News wire article from: The America's Intelligence Wire December 17, 2004 700+ words
...earnings. He doubted Pfizer would pull Celebrex or its alternative arthritis...is the probability that Pfizer removes Celebrex or Bextra from the market...rheumatoid arthritis. Pfizer's announcement on Celebrex comes three months after...
UPDATE 10-Pfizer plunges as cardiac risk found in Celebrex study.
News wire article from: The America's Intelligence Wire December 17, 2004 700+ words
...inhibitors, which includes Celebrex and Pfizer's Bextra. "I don't...on earnings. He doubted Pfizer would pull Celebrex or its alternative arthritis...take is the probability that Pfizer removes Celebrex or Bextra from the market...
Pfizer's Celebrex also found to have CD risks; company halts drug's DTC...
Newspaper article from: Pharma Marketletter January 3, 2005 700+ words
...COX-2 inhibitor Celebrex (celecoxib...events to placebo, Pfizer has, at the request...December 17 caused Pfizer's share price...DTC promotion of Celebrex saw the stock drop...adding: "we believe Pfizer stock could be weak...imminent withdrawal of Celebrex is Winton Gibbons...
Hagens Berman: Pfizer Settles Lawsuits Over Prescription Pain Killers Bextra...
Press release article from: PR Newswire October 17, 2008 700+ words
...million settlement with Pfizer on behalf of purchasers of Celebrex and Bextra in a suit claiming...who purchased the drug Celebrex, claiming Pfizer failed to disclose serious...www.hbsslaw.com/pfizer_celebrex_lawsuit.html. About...
For more facts and information, see all results
©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily